Evogene annual current ratio
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Current Ratio Growth & History (EVGN)
Evogene's current ratio was 4.54 for fiscal 2025.
View full Evogene company overviewEvogene annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.54 | 3.38 | +293.02% |
| 2024 | 2024-12-31 | 1.15 | −3.81 | −76.74% |
| 2023 | 2023-12-31 | 4.96 | −1.75 | −26.04% |
| 2022 | 2022-12-31 | 6.71 | −1.56 | −18.81% |
| 2021 | 2021-12-31 | 8.27 | 2.91 | +54.35% |
| 2020 | 2020-12-31 | 5.36 | −3.18 | −37.23% |
| 2019 | 2019-12-31 | 8.53 | −1.68 | −16.49% |
| 2018 | 2018-12-31 | 10.22 | −5.39 | −34.54% |
| 2017 | 2017-12-31 | 15.61 | −1.52 | −8.88% |
| 2016 | 2016-12-31 | 17.13 | — | — |
Evogene quarterly current ratio
Q4.16
Q4.17
Q4.18
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.57 | 1.68 | +89.13% |
| Q1 2026 | 2026-03-31 | 2.79 | 1.73 | +163.70% |
| Q4 2025 | 2025-12-31 | 4.54 | 3.38 | +293.02% |
| Q3 2025 | 2025-09-30 | 5.11 | — | — |
| Q2 2025 | 2025-06-30 | 1.89 | 0.30 | +19.12% |
| Q1 2025 | 2025-03-31 | 1.06 | — | — |
| Q4 2024 | 2024-12-31 | 1.15 | −3.81 | −76.74% |
| Q2 2024 | 2024-06-30 | 1.58 | −4.01 | −71.68% |
| Q4 2023 | 2023-12-31 | 4.96 | −1.75 | −26.04% |
| Q2 2023 | 2023-06-30 | 5.59 | −1.22 | −17.86% |
| Q4 2022 | 2022-12-31 | 6.71 | −1.56 | −18.81% |
| Q2 2022 | 2022-06-30 | 6.80 | −5.94 | −46.60% |
| Q4 2021 | 2021-12-31 | 8.27 | 2.91 | +54.35% |
| Q2 2021 | 2021-06-30 | 12.74 | 4.48 | +54.18% |
| Q4 2020 | 2020-12-31 | 5.36 | −3.18 | −37.23% |
| Q2 2020 | 2020-06-30 | 8.26 | — | — |
| Q4 2019 | 2019-12-31 | 8.53 | −1.68 | −16.49% |
| Q4 2018 | 2018-12-31 | 10.22 | −5.39 | −34.54% |
| Q4 2017 | 2017-12-31 | 15.61 | −1.52 | −8.88% |
| Q4 2016 | 2016-12-31 | 17.13 | — | — |
Evogene current ratio trends
Over the last five fiscal years, Evogene's current ratio decreased from 5.36 to 4.54, a change of −0.82. The latest reported quarter, Q2 2026, shows 3.57.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evogene source filings ↗